Poxel S.A. (EPA:POXEL)
France · Delayed Price · Currency is EUR 0.2020
-0.0075 (-3.58%)
Aug 3, 2026, 1:50 PM CET
Poxel Market Cap
Poxel has a market cap or net worth of €11.26 million as of August 3, 2026. Its market cap has decreased by -62.55% in one year.
Market Cap
11.26M
Enterprise Value
71.21M
Revenue
7.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.20
ChartMarket Cap Chart
Since February 6, 2015, Poxel's market cap has decreased from 193.09M to 11.26M, a decrease of -94.17%. That is a compound annual growth rate of -21.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 11.26M | -10.47% |
| Dec 31, 2025 | 12.57M | 69.26% |
| Dec 31, 2024 | 7.43M | -61.80% |
| Dec 29, 2023 | 19.45M | -28.41% |
| Dec 30, 2022 | 27.16M | -80.72% |
| Dec 31, 2021 | 140.90M | -22.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 34.06M |
| Advicenne | 23.86M |
| genOway Société anonyme | 22.50M |
| GenSight Biologics | 19.13M |
| Aelis Farma | 13.92M |
| NFL Biosciences | 11.02M |
| Aton | 8.45M |
| Oncodesign Precision Medicine Société anonyme | 6.13M |